| P/E (FY) | — | Sales (TTM) | $1.43B |
| Earnings (TTM) | $107.1M | ROE | −19.24% |
| Net Margin | −17.47% | ROIC | 12.81% |
| Debt / Equity | 0.31 | TD / EBITDA | — |
| EPS Growth 3Y | — | Sales Growth 3Y | 10.75% |
LivaNova is a medical technology company that designs, develops, manufactures, and markets products and therapies across the United States, Europe, and internationally through Cardiopulmonary and Neuromodulation segments. The Cardiopulmonary segment provides heart-lung machines, oxygenators, autotransfusion systems, perfusion tubing, and cannulae. The Neuromodulation segment offers the VNS Therapy System, an implantable pulse generator and lead that stimulates the vagus nerve, along with related surgical equipment.
| Market Cap | $4.51B | Trading Days | 2706 |
| 52W High | 85.27 |
| 52W Low | 41.02 |
| % Off High | −3.73% |
| YTD | 33.41% | 1Y | 88.89% |
| 3Y | 42.02% | 5Y | −4.47% |
| 10Y | 58.78% | Since incept. (ann.) | 1.50% |
US 51% · Locations Excluding The United States And Europe 26% · Europe 19% · GB 4%
| Ann. Volatility (1Y) | 38.45% | Ann. Volatility (3Y) | 39.92% |
| Sharpe (1Y) | 1.86 | Sharpe (3Y) | 0.50 |
| Max Drawdown (1Y) | −18.89% | Max Drawdown (3Y) | −47.23% |
| Beta (3Y, vs SPY) | 0.84 |
| Ticker | Name | Mkt cap | P/E |
|---|---|---|---|
| ITGR | Integer Holdings Corp | $3.41B | 34.7 |
| TMDX | TransMedics Group, Inc. | $2.64B | 15.7 |
| AXGN | Axogen, Inc. | $2.19B | — |
| BLFS | BIOLIFE SOLUTIONS INC | $1.56B | — |
| CNMD | CONMED Corp | $1.36B | 29.3 |
| CBLL | Ceribell, Inc. | $676.5M | — |
| CV | CapsoVision, Inc | $330.8M | — |
| ELMD | Electromed, Inc. | $326.9M | 46.4 |
| MDT | Medtronic plc | $111.21B | 23.3 |
| STXS | Stereotaxis, Inc. | $125.1M | — |
| VANI | Vivani Medical, Inc. | $113.0M | — |
| OM | Outset Medical, Inc. | $87.5M |
| — |
